Long-term impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals (ACTG 5097s).

HIV Clinical Trials
David B CliffordA5097s Study Team

Abstract

Efavirenz (EFV) is an antiretroviral (ARV) drug associated with neuropsychological effects. Limited data describing the long-term impact of EFV-based regimens on neuropsychological performance over more than 3 years are available. We enrolled a subset of participants from a large initially EFV placebo-controlled trial of therapies for HIV subjects naïve to ARV treatment (A5095). Clinical follow-up continued for 184 weeks of study. Subjects were assessed with brief neuropsychological testing, a symptom questionnaire of EFV-associated symptoms, the Pittsburgh Sleep Index, Center for Epidemiologic Studies-Depression Scale, and an anxiety rating interview. Over 184 weeks on EFV, the median NPZ3 score in 86 evaluable patients improved from baseline by +0.5 (p < .01); all components improved, although higher EFV levels were associated with slightly lower responses. Overall symptom scores did not change, while EFV-associated CNS symptoms increased (p = .01). Median change of bad dream sleep scores and anxiety increased from the baseline while global depression score decreased. In participants who continued EFV-based regimens, neuropsychological performance improvement from baseline was maintained over 3 years. EFV-based treatment was ...Continue Reading

Associated Clinical Trials

References

Apr 6, 2002·Journal of Neurovirology·Ned SacktorLeon Epstein
Dec 31, 2002·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Michele L TurnerEdward P Acosta
Apr 30, 2004·The New England Journal of Medicine·Roy M GulickUNKNOWN AIDS Clinical Trials Group Study A5095 Team
Nov 17, 2005·Annals of Internal Medicine·David B CliffordRoy M Gulick
Jan 5, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Heather J RibaudoUNKNOWN Adult AIDS Clinical Trials Group Study
Aug 15, 2006·JAMA : the Journal of the American Medical Association·Roy M GulickUNKNOWN AIDS Clinical Trials Group (ACTG) A5095 Study Team
Aug 5, 2008·JAMA : the Journal of the American Medical Association·Scott M HammerUNKNOWN International AIDS Society-USA

❮ Previous
Next ❯

Citations

Dec 24, 2013·CNS Drugs·Michael S AbersJoseph S Kass
Jun 3, 2011·The Pediatric Infectious Disease Journal·Renate StrehlauElaine J Abrams
Jul 19, 2013·Current HIV/AIDS Reports·Serena Spudich
Nov 24, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·UNKNOWN Mind Exchange Working Group
Feb 23, 2013·Scandinavian Journal of Infectious Diseases·Peter Derek Christian LeutscherCarsten Schade Larsen
Aug 15, 2015·AIDS and Behavior·C AllavenaUNKNOWN COREVIH-Pays de la Loire Troubles du Sommeil Study Group
Jul 31, 2013·Expert Opinion on Drug Safety·Eric H Decloedt, Gary Maartens
Jul 23, 2013·Enfermedades infecciosas y microbiología clínica·Inmaculada PoquetCarlos Tornero
Feb 24, 2016·Expert Review of Anti-infective Therapy·Razia GaidaBrian Godman
Sep 27, 2015·Journal of Neurovirology·Qing MaUNKNOWN CHARTER Group
Jul 24, 2015·The Journal of Antimicrobial Chemotherapy·Nadezda ApostolovaJuan V Esplugues
Aug 13, 2014·Journal of Sleep Research·Arthur A SimenIain Fraser
Oct 26, 2013·The Lancet Infectious Diseases·David B Clifford, Beau M Ances
May 15, 2015·Pharmacogenetics and Genomics·Ellen M McDonaghTeri E Klein
Apr 29, 2015·Current Infectious Disease Reports·Mark R EthertonKevin L Ard
Nov 22, 2014·Current Psychiatry Reports·Maria Giulia NanniLuigi Grassi
Aug 19, 2016·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Glenn J Treisman, Olivia Soudry
Sep 23, 2016·The Journal of Antimicrobial Chemotherapy·Uriel SandkovskySusan Swindells
Nov 18, 2018·Expert Review of Clinical Pharmacology·Giovanni GuaraldiCristina Mussini
Aug 15, 2014·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Dixon ChibandaMelanie Abas
Sep 20, 2019·Internal Medicine·Tomohiro HosodaToshio Naito
Jan 29, 2020·Current Opinion in HIV and AIDS·Aaron Richterman, Paul E Sax
Feb 12, 2020·The Journal of Pharmacy and Pharmacology·Josué Jeyzon de Lima Soares ValerianoRafael Lima Guimarães
Jul 10, 2012·Journal of Developmental and Behavioral Pediatrics : JDBP·Kenneth D GadowSharon Nachman
Dec 17, 2010·AIDS·Judith SchoutenPeter Portegies
Jan 10, 2012·Current Opinion in HIV and AIDS·Shahin Lockman, Paul Sax
Nov 15, 2019·The Journal of the Association of Nurses in AIDS Care : JANAC·Xueling XiaoDeborah Koniak-Griffin
Jan 8, 2020·AIDS Research and Therapy·Phillip ChanUNKNOWN RV254/SEARCH 010 Research Team
Jun 1, 2013·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Charlene E GamaldoMichael T Smith
Mar 27, 2020·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Leah H RubinDionna W Williams

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.